logo

For the Inventor, By the Inventor

Mundeline, IL, United States of America

Richard J Johnson

This inventor holds 21 USPTO granted patents, primarily in Medical Devices. Top assignees: Baxter International Inc., Baxalta Gmbh, Baxter Healthcare Sa. Active years: 1984-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard J Johnson. Retrieved from https://idiyas.com/inventor/richard-j-johnson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 90.5

Average Co-Inventor Count = 2.2

ph-index = 10

Forward Citations = 233(Granted Patents)


Location History:

  • Westmont, IL (US) (1984)
  • New London, WI (US) (1991)
  • Arlington, VA (US) (2000)
  • Mundeline, IL (US) (1999 - 2008)
  • Mundelein, IL (US) (1989 - 2016)

Company Filing History:

goldMedal11 out of 2,533 
 
Baxter International Inc.
 patents
silverMedal6 out of 153 
 
Baxalta Gmbh
 patents
bronzeMedal3 out of 1,201 
 
Baxter Healthcare Sa
 patents
4. 1 out of 809 
 
Baxter Travenol Laboratories, Inc.
 patents
5. 1 out of 1,793 
 
Edwards Lifesciences Corporation
 patents
6. 1 out of 1 
 
Innate Biotech, Inc.
 patent
7. 4 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2016

Loading Chart...
Areas of Expertise:
Factor H
Rheumatoid Arthritis
Transplantation
Complement Activation
Medical Coatings
Leukodepletion
Blood Cell Separation
Nucleophilic Material
Enzymatic Digestion
Peptides
Fluid Filtration
Portable Grill
21 patents (USPTO):Explore Patents
1. 9248162 - Factor H for treatment of rheumatoid arthritis (2016-02-02),
2. 9138466 - Factor H for transplantation (2015-09-22),
3. 9109044 - Manufacture of factor H (FH) and FH-derivatives from plasma (2015-08-18),
4. 8822656 - Manufacture of factor H (FH) and FH-derivatives from plasma (2014-09-02),
5. 8349813 - Destruction of microbial products by enzymatic digestion (2013-01-08),
6. 8304524 - Manufacture of factor H (FH) and FH-derivatives from plasma (2012-11-06),
7. 7422606 - Medical devices and products having coatings applied thereto (2008-09-09),
8. 7348401 - Peptides that inhibit complement activation (2008-03-25),
9. 6648922 - Method for producing improved medical devices and devices so produced (2003-11-18),
10. 6306454 - Method for producing improved medical devices and devices so produced (2001-10-23),
11. 6129096 - Dog litter clean up kit and method (2000-10-10),
12. 6045701 - Method of filtering a fluid suspension with a membrane having a (2000-04-04),
13. 6028170 - Analogs of hirudin (2000-02-22),
14. 5972217 - Blood cell separation devices having a membrane with particular coating (1999-10-26),
15. 5837808 - Analogs of hirudin (1998-11-17),

Title: Richard J. Johnson: Innovator in Medical Treatment and Transplantation

Introduction

Richard J. Johnson is a noted inventor based in Mundelin, Illinois, with a remarkable portfolio of 21 patents. His work primarily focuses on medical innovations that provide solutions for critical health issues such as rheumatoid arthritis and allograft rejection.

Latest Patents

Among his most recent inventions, Johnson has developed methods that utilize Factor H for the treatment of rheumatoid arthritis. This invention outlines a composition comprising Factor H, aimed at preventing or inhibiting allograft rejection in recipients. Additionally, Johnson's patents also emphasize the potential effectiveness of administering immunosuppressants in conjunction with Factor H to enhance treatment outcomes.

Career Highlights

Johnson has made significant contributions to the field of biomedical research through his roles at prominent companies. He has worked with Baxter International Inc. and Baxalta GmbH, where he contributed to the development of innovative medical therapies.

Collaborations

Throughout his career, Johnson has collaborated with industry professionals, including notable colleagues Neng S. Ung-Chhun and Shawn F. Bairstow. These partnerships underscore the collective effort in advancing medical technology and improving patient care through innovative therapies.

Conclusion

Richard J. Johnson's contributions to medical science through his patents demonstrate the vital role of innovation in addressing healthcare challenges. His focus on Factor H as a treatment modality illustrates the potential for groundbreaking advancements in the field of immunology and transplantation, ultimately impacting the lives of countless patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…